Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GKB OphthalmicsBOM:533212 +0.07%61 Net Current Asset Value is ₹56.79 as of Mar. 2026, which is 100% below its 10-year median of 1.50. GuruFocus rates BOM:533212 with a GF Score™ of 61/100 and a GF Value™ of ₹163.44 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 563 Medical Devices & Instruments companies, GKB Ophthalmics ranks better than 95.2% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
GKB Ophthalmics's net current asset value per share for the quarter that ended in Mar. 2026 was ₹56.79.
The historical rank and industry rank for GKB Ophthalmics's Net Current Asset Value or its related term are showing as below:
BOM:533212'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.73 Med: 1.5 Max: 2
Current: 1
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of GKB Ophthalmics was 2.00. The lowest was 0.73. And the median was 1.50.
BOM:533212's Price-to-Net-Current-Asset-Value is ranked better than 95.2% of 563
companies
in the Medical Devices & Instruments industry
Industry Median: 5.01
vs BOM:533212: 1.00
GKB Ophthalmics (BOM:533212) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
GKB Ophthalmics Net Current Asset Value Related Terms
GKB Ophthalmics Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for GKB Ophthalmics's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:533212 vs ISRG, BDX, MDLN: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, GKB Ophthalmics's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GKB Ophthalmics Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, GKB Ophthalmics's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where GKB Ophthalmics's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹56.79 mean?
GKB Ophthalmics (BOM:533212) has a Net Current Asset Value of ₹56.79 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on GKB Ophthalmics and its competitors. This is 3686% above median its historical median of 1.50. Over the past decade, GKB Ophthalmics' Net Current Asset Value has ranged from 0.73 to 2.00. According to the industry distribution chart, GKB Ophthalmics ranks #27 out of 563 companies in the Medical Devices & Instruments industry, placing it in the top 4.8%.
Is GKB Ophthalmics' Net Current Asset Value too high?
GKB Ophthalmics' current Net Current Asset Value of ₹56.79 is 3686% above median its 10-year median of 1.50. Over the past 10 years, this metric has ranged from a low of 0.73 to a high of 2.00. Based on the distribution chart, GKB Ophthalmics ranks #27 out of 563 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, GKB Ophthalmics has a GF Score™ of 61/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Net Current Asset Value compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, GKB Ophthalmics ranks #27 out of 563 companies for Net Current Asset Value. This places GKB Ophthalmics in the top 5% of its industry — outperforming the majority of peers. The industry median Net Current Asset Value is 5.01. Historically, GKB Ophthalmics' own Net Current Asset Value has ranged from 0.73 to 2.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.01, based on 563 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on GKB Ophthalmics and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GKB Ophthalmics's current Net Current Asset Value is ₹56.79, which is 3686% above median its own 10-year median of 1.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹163.44, compared to a current price of ₹56.97 — trading 65.1% below its estimated fair value. The current Net Current Asset Value is ₹56.79, which is 3686% above median its 10-year median of 1.50. GKB Ophthalmics' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Net Current Asset Value is ₹56.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?
Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued.
The current stock price of ₹56.97 is trading 65.1% below its estimated GF Value™ of ₹163.44.
GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.
Key valuation signals for BOM:533212:
Net Current Asset Value: ₹56.79 (3686% above median its 10-year median of 1.50)
GF Value™: ₹163.44 vs. price of ₹56.97 (65.1% below fair value)
No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
61GF Score
Get the complete analysis for BOM:533212
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:533212 has been successfully added to your 
